Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and phosphoserine

cyc 202 has been researched along with phosphoserine in 3 studies

*Phosphoserine: The phosphoric acid ester of serine. [MeSH]

*Phosphoserine: The phosphoric acid ester of serine. [MeSH]

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(phosphoserine)		Trials
(phosphoserine)		Recent Studies (post-2010) (phosphoserine)
97973933,3373830

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ball, HM; Blaydes, JP; Hupp, TR; Luciani, MG; Pospisilova, S; Vojtesek, B1
Gueorguieva, M; Horky, M; Wesierska-Gadek, J1
Balk, SP; Bubley, GJ; Chen, S; Xu, Y; Yuan, X1

Other Studies

3 other study(ies) available for cyc 202 and phosphoserine

ArticleYear
Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription.
    The Journal of biological chemistry, 2001, Feb-16, Volume: 276, Issue:7

    Topics: Antibodies, Monoclonal; DNA; Enzyme Inhibitors; Humans; Phosphorylation; Phosphoserine; Point Mutation; Purines; Roscovitine; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays

2001
Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Caspase 3; Caspases; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Potentials; Mitochondria; Phosphorylation; Phosphoserine; Proteins; Purines; Roscovitine

2005
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Oct-24, Volume: 103, Issue:43

    Topics: Androgens; CDC2 Protein Kinase; Cell Line, Tumor; Humans; Male; Phosphorylation; Phosphoserine; Prostatic Neoplasms; Protein Kinase Inhibitors; Purines; Receptors, Androgen; Roscovitine; Transcription, Genetic

2006